Nasal Polyps: Clinical Trials

21 trials for Nasal Polyps, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed. 21 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 221Completed 21
Phase 32Completed 2

Follow Nasal Polyps: new trials by email Literature Review of Nasal Polyps trials Research Report on Nasal Polyps

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Verekitug (UPB-101), Placebo - Chronic Rhinosinusitis With Nasal Polyps
Phase 2CompletedUpstream Bio Inc.812023-12-182026-09-18
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
TQC2731 injection, TQC2731 matching placebo - Chronic Sinusitis, Nasal Polyps
Phase 2CompletedChia Tai Tianqing Pharmaceutical Group Co., Ltd.802023-12-082025-04-16
Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)
CM310, Placebo - Chronic Rhinosinusitis (Diagnosis), Nasal Polyps
Phase 2CompletedKeymed Biosciences Co.Ltd562021-04-062022-06-29
GB001 in Adult Participants With Chronic Rhinosinusitis
GB001, Placebo - Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP), Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Phase 2CompletedGB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.972019-05-162021-08-23
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
Ifetroban, Placebo - Nasal Polyps, Asthma, Aspirin-Induced
Phase 2CompletedBrigham and Women's Hospital382018-04-262023-07-14
Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis
Emthexate, Prednol, Mometasone Furoate - Nasal Polyposis
Phase 2CompletedDokuz Eylul University412017-09-022020-08-31
Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis
Benralizumab, Placebo - Chronic Rhinosinusitis (Diagnosis), Nasal Polyps
Phase 2CompletedJohns Hopkins University332017-07-012021-02-11
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis
botox injection Multiguide - Chronic Disease, Nasal Polyposis
Phase 2CompletedNorwegian University of Science and Technology112016-10-012021-11-05
Anti-Inflammatory Agent in Sinusitis
AZ compound, Collection of Biological Specimens, Intranasal corticosteroid - Nasal Polyps
Phase 2CompletedNorthwestern University432016-06-202022-05-25
Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
AK001 low dose, AK001 high dose, Placebo - Nasal Polyposis
Phase 2CompletedAllakos Inc.402016-04-012021-01-25
Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
dexpramipexole - Chronic Sinusitis With Nasal Polyps and Eosinophilia
Phase 2CompletedKnopp Biosciences202014-08-012021-05-18
An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis
Placebo (for dupilumab), Dupilumab, Mometasone furoate nasal spray - Nasal Polyps
Phase 2CompletedSanofi602013-08-012017-06-26
Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps
S8 Sinus Implant, Sham procedure, Mometasone furoate nasal spray - Chronic Sinusitis, Nasal Polyps
Phase 2 / Phase 3CompletedIntersect ENT1002013-01-012018-07-20
Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial
placebo, doxycycline 100 mg - Chronic Rhinosinusitis, Nasal Polyps
Phase 2CompletedUniversity Hospital, Ghent332011-11-222018-06-15
Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps
budesonide, placebo - Nasal Polyps
Phase 2 / Phase 3CompletedBeijing Tongren Hospital572010-09-012014-10-10
Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis
Xolair placebo, Xolair (omalizumab) - Chronic Rhinosinusitis, Nasal Polyps
Phase 2CompletedMassachusetts General Hospital272009-12-012017-06-14
Mepolizumab in Nasal Polyposis
Mepolizumab, Placebo, Run In Medication - Nasal Polyps
Phase 2CompletedGlaxoSmithKline1092009-05-122021-04-12
Mint Tea for the Treatment of Nasal Polyps
Mint tea high in rosmarinic acid, Mint tea low in rosmarinic acid - Nasal Polyps
Phase 2CompletedHamilton Health Sciences Corporation222007-05-012011-12-09
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
Omalizumab, Placebo - Nasal Polyposis, Asthma
Phase 2CompletedUniversity Hospital, Ghent232006-12-012011-07-13
A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
Intranasal Beclomethasone aerosol, Intranasal Beclomethasone spray - Nasal Polyps
Phase 2CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's302006-11-232017-08-28

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Asthma (2)  ·  Disease (2)  ·  Eosinophilia (2)  ·  Rhinosinusitis (2)  ·  Sinusitis (2)  ·  Asthma, Aspirin-Induced (1)  ·  Bites and Stings (1)  ·  Chronic Disease (1)  ·  Nose Diseases (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Paranasal Sinus Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Rhinitis (1)

Broader conditions

Pathological Conditions, Anatomical (21)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Polyps (21)  ·  Nose Diseases (20)  ·  Otorhinolaryngologic Diseases (20)  ·  Respiratory Tract Diseases (20)  ·  Infections (4)  ·  Respiratory Tract Infections (4)  ·  Bronchial Diseases (3)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Pathologic Processes (3)  ·  Respiratory Hypersensitivity (3)  ·  Chemically-Induced Disorders (2)

Interventions

Mometasone Furoate (4)  ·  Omalizumab (2)  ·  Adrenal Cortex Hormones (1)  ·  Beclomethasone (1)  ·  Biomarkers (1)  ·  Botulinum Toxins, Type A (1)  ·  Budesonide (1)  ·  Dexpramipexole (1)  ·  Dosage Forms (1)  ·  Doxycycline (1)  ·  Fluticasone (1)  ·  Jogging (1)  ·  MeRho-Az compound (1)  ·  Methotrexate (1)  ·  Methylprednisolone (1)

Sponsors

University Hospital, Ghent (3)  ·  Allakos Inc. (1)  ·  Beijing Tongren Hospital (1)  ·  Brigham and Women's Hospital (1)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  Dokuz Eylul University (1)  ·  GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. (1)  ·  GlaxoSmithKline (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Intersect ENT (1)  ·  Johns Hopkins University (1)  ·  Keymed Biosciences Co.Ltd (1)  ·  Knopp Biosciences (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Massachusetts General Hospital (1)

Countries

United States (9)  ·  Belgium (6)  ·  China (3)  ·  Germany (3)  ·  Spain (3)  ·  Czechia (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  Norway (1)  ·  Poland (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)

Top investigators

Claus Bachert, MD, PhD (2)  ·  Anju T Peters, MD (1)  ·  Claus Bachert (1)  ·  Ellen J Dutta, MD (1)  ·  Elliot Israel, MD (1)  ·  Jody Tversky, MD (1)  ·  Jorge A Mazza, MD (1)  ·  Joseph K Han, MD (1)  ·  Keith D Forwith, MD (1)  ·  Lars Jacob Stovner, md prof (1)  ·  Luo Zhang (1)  ·  Luo Zhang, MD (1)  ·  Paul K. Keith (1)

Results publications

PMID 33710614, PMID 26836729, PMID 26992115, PMID 30488542, PMID 30954643, PMID 31306495, PMID 32075470, PMID 33595845, PMID 34110505, PMID 34437720, PMID 34633904, PMID 34848949, PMID 35524339, PMID 37483544, PMID 39393433

NIH funding

2008 (1), 2015 (1), 2019 (1), 2023 (1)